Cargando…
The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling
BACKGROUND: A significant level of CD70 can be detected in various types of tumor tissues and CD27 is expressed on Treg cells, but CD70 expression is low in normal tissues. The interaction between CD70 and CD27 can stimulate the proliferation and survival of cancer cells and increase the level of so...
Autores principales: | Li, Song, Chen, Dianze, Guo, Huiqin, Liu, Dandan, Yang, Chunmei, Zhang, Ruliang, Wang, Tianxiang, Zhang, Fan, Bai, Xing, Yang, Yanan, Sun, Nana, Zhang, Wei, Zhang, Li, Zhao, Gui, Peng, Liang, Tu, Xiaoping, Tian, Wenzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578964/ https://www.ncbi.nlm.nih.gov/pubmed/37849799 http://dx.doi.org/10.3389/fonc.2023.1240061 |
Ejemplares similares
-
IMM0306, a fusion protein of CD20 mAb with the CD47 binding domain of SIRPα, exerts excellent cancer killing efficacy by activating both macrophages and NK cells via blockade of CD47-SIRPα interaction and FcɣR engagement by simultaneously binding to CD47 and CD20 of B cells
por: Yu, Jifeng, et al.
Publicado: (2022) -
IMM47, a humanized monoclonal antibody that targets CD24, exhibits exceptional anti-tumor efficacy by blocking the CD24/Siglec-10 interaction and can be used as monotherapy or in combination with anti-PD1 antibodies for cancer immunotherapy
por: Li, Song, et al.
Publicado: (2023) -
SIRPα-Fc fusion protein IMM01 exhibits dual anti-tumor activities by targeting CD47/SIRPα signal pathway via blocking the “don’t eat me” signal and activating the “eat me” signal
por: Yu, Jifeng, et al.
Publicado: (2022) -
Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc
por: Dadas, Osman, et al.
Publicado: (2023) -
Crystal Structure of Human CD47 in Complex with Engineered SIRPα.D1(N80A)
por: Yu, Jifeng, et al.
Publicado: (2022)